Uganda

in page functions
[French]
Uganda
Total population (2017) 41,652,849
Birth cohort (2017) 1,738,263
Surviving Infants (surviving to 1 year per year, 2017) 1,640,397
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 38/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 55/1000
World Bank Index, IDA (2015) 3.74
Gross Nation Income (per capita US$, 2015) 700
Co-financing group (2017) Initial self-financing
No. of districts/territories (2016) 112

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Uganda

Type of support

Approvals

2001-2021 (US$)
(26 Sep 2017)

Commitments

2001-2021 (US$)
(26 Sep 2017)

Disbursements

2000-2017 (US$)
(26 Sep 2017)

% Disbursed

(26 Sep 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $353,185,928 $482,461,928 $322,111,691
Cold Chain Equipment Optimisation Platform (CCEOP) $6,648,068 $6,648,068
Health system strengthening (HSS 1) $19,242,000 $19,242,000 $16,327,658 85%
Health system strengthening (HSS 2) $13,110,000 $30,600,000
HPV (NVS) $16,803,821 $39,024,821 $16,729,021 100%
Immunisation services support (ISS) $9,230,520 $9,230,520 $9,230,520 100%
Injection Safety Devices (NVS) $427,000 $2,468,000 $217,127 51%
Injection safety support (INS) $1,207,299 $1,207,299 $1,207,299 100%
IPV (NVS) $9,259,010 $9,259,010 $3,472,415 38%
Meningitis A - campaign (NVS) $5,538,937 $5,538,937 $5,538,937 100%
Meningitis A - operational costs (OPC) $4,552,647 $4,552,647 $4,366,265 96%
Penta (NVS) $169,051,800 $186,721,300 $169,051,496 100%
Pneumo (NVS) $86,221,326 $141,197,326 $91,805,453 106%
Rotavirus (NVS) $7,728,000 $21,100,000 0%
Vaccine Introduction Grant (VIG) $4,165,500 $5,672,000 $4,165,500 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Uganda DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 93%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2010) 72.00%
Household survey: DTP3 coverage for female (2010) 71.00%
Household survey: Last DTP3 survey (2010) 72%
% districts achieving > 80% DTP3 coverage (2016) 90%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 82%

Breakdown of support

Non-vaccine support Vaccine support
11% 89%
$35,297,242 $286,814,449

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Uganda

08 December 2016

Syrian children

Gavi to support immunisation of children in Syria

Gavi Board decisions also taken to strengthen emergency vaccine stockpiles and to accelerate human papillomavirus (HPV) vaccine programme to protect 40 million girls against cervical cancer by 2020.

21 September 2016

Gavi Philips 1

Using data to map immunisation in the developing world

Philips and Gavi, the Vaccine Alliance, are teaming up to improve the quality of immunisation data and its collection in primary and community healthcare, with Uganda as a test ground.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

close icon

modal window here